Sarah Campbell

Sarah Campbell ( is a writer living in Seattle, Washington.

Associated articles

IEEE PULSE, Feature July/August 2017
The Quantified Patient Checks In
Larry Smarr Like eight-year-olds who can’t let go of a good joke, Larry Smarr’s nurses and doctors kept coming to him with the same question: “Have you passed gas yet?” Answering this question in the affirmative is, Smarr explains, deadpan, “the... Read more
IEEE PULSE, Feature November/December 2015
Baby, Where Did You Get Those Eyes?
Mark Sagar. Mark Sagar is changing the way we look at computers by giving them faces—disconcertingly realistic human faces. Sagar first gained widespread recognition for his pioneering work in rendering faces for Hollywood movies, including Avatar and King Kong. With a... Read more
IEEE PULSE, Feature May/June 2018
The Robotics Revolution Will Be Soft
When soft robotics first emerged, it was defined (as breakthroughs often are) by what it was that its traditional counterparts were not, i.e., soft. A decade in, the nomenclature remains apt. The pliant materials used in soft robotics are often both... Read more
IEEE PULSE, Feature July/August 2016
Danielle Bassett
Here’s the drill. Upon waking, count down from 100 to one as quickly as possible. Next, recite the alphabet, giving each letter a corresponding word partner (A, antler; B, bargain; C, cartoon, for example). After that, crank out several lists,... Read more
IEEE PULSE, Cover Story September/October 2018
The Space Between
Around 2008, endoscopists David Carr-Locke and Petros Benias began to notice an unfamiliar pattern in the bile duct during endomicroscopy, which didn’t look like anything they knew from pathology. Their confusion as to what it was persisted, so they brought... Read more
IEEE PULSE, Feature September/October 2016
The Precise–and Wild–Genomics Revolution
Figure 1: This 2001 photo of DNA sequencing equipment at the NIH’s Intramural Research Center, Advanced Technology Center, in Gaithersburg, Maryland, suggests the “hundreds, hundreds, hundreds” of machines required at the time. (Photo courtesy of Eric Green, NHGRI, NIH.) In the... Read more
IEEE PULSE, Cover Story March/April 2019
Will Biotechnology Stop Aging?
Could biotechnology stop aging? The answer may be yes, no, or something in between, depending on who is being asked and what it means to “stop” aging. For those at one end of the spectrum— life extension seekers (including some... Read more
IEEE PULSE, Feature May/June 2015
Changing the Calculus of Pediatric Product Development
First, Deliece Hofen drops the pill into hot water to soften the outside coating. Then, she slices through the center of the pill with an X-ACTO knife and squeezes the isotretinoin inside into a syringe. With the drug in liquid... Read more
IEEE PULSE, Feature May/June 2017
Engineering Tissues to Heal Themselves
Sufferers of osteoarthritis are all too aware of the daily pain and impairment of swollen joints, of having to give up sports—and jobs—due to cartilage defects. What they may be less aware of is that three-dimensional (3-D) bioprinting and bioink... Read more
IEEE PULSE, Cover Story September/October 2019
Microbial Treatments for the Mind
For $99, you can obtain a kit that includes two cotton swabs and instructions for properly collecting your own stool sample, along with oral and skin samples. Upon shipping those specimens to the Knight Lab in La Jolla, CA, you... Read more
IEEE PULSE, Feature July/August 2015
Fidelity and Validity in Medical Simulation
The girl looks about 10 years old. She lies quietly on the emergency room exam bed, her eyes wide. Half an hour ago she was swinging—a little too wildly—from monkey bars in the park. Then, she fell. “Hey kiddo,” says Dr.... Read more
IEEE PULSE, Feature September/October 2020
From Face-to-Face to FaceTime
In a Jetsons episode from 60 years ago, Elroy, the youngest Jetson, tries to get out of taking a space calculus test at school by telling his mom he’s sick. “I think I have Venus Virus,” he says. His mom doubts him, but summons a doctor anyway... Read more
IEEE PULSE, Feature March/April 2021
The Search for a Drug to End Alzheimer’s
On November 6, 2020, researchers who have been laboring to find a drug that will treat Alzheimer’s disease (AD) dialed in to a public meeting of the U.S. Food and Drug Administration’s (FDA) Peripheral and Central Nervous System Drugs Advisory Committee. The committee would review drug trials of Biogen’s aducanumab, and conclude with a vote on the drug’s safety and efficacy in treating AD. The independent advisors’ decision wouldn’t be the official one for aducanumab, but their vote usually mirrors the final FDA decision... Read more